Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat

[1]  J. Deniau,et al.  Electrophysiological evidence for non-dopaminergic mesocortical and mesolimbic neurons in the rat , 1980, Brain Research.

[2]  J. Deniau,et al.  Electrophysiological identification of mesencephalic ventromedial tegmental (VMT) neurons projecting to the frontal cortex, septum and nucleus accumbens , 1980, Brain Research.

[3]  J. Glowinski,et al.  Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation , 1980, Nature.

[4]  J. Glowinski,et al.  Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat , 1980, Brain Research.

[5]  C. Carter,et al.  Effect of 6‐Hydroxydopamine Lesions of the Medial Prefrontal Cortex on Neurotransmitter Systems in Subcortical Sites in the Rat , 1980, Journal of neurochemistry.

[6]  Hervé Simon,et al.  Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase , 1979, Brain Research.

[7]  J. Glowinski,et al.  Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat , 1979, Neuroscience Letters.

[8]  B. Berger,et al.  Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles , 1979, Neuroscience.

[9]  O. Phillipson.  Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat , 1979, The Journal of comparative neurology.

[10]  J. Glowinski,et al.  Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat , 1979, Brain Research.

[11]  G. Gessa,et al.  Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam. , 1978, Life sciences.

[12]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[13]  J. Glowinski,et al.  Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat , 1978, Brain Research.

[14]  M. Le Moal,et al.  Locomotor activity after various radiofrequency lesions of the limbic midbrain area in the rat. Evidence for a particular role of the ventral mesencephalic tegmentum. , 1976, Life sciences.

[15]  J. Glowinski,et al.  Selective activation of the mesocortical DA system by stress , 1976, Nature.

[16]  D. Segal,et al.  Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways , 1976, Brain Research.

[17]  H. Hillman,et al.  THE UPTAKE OF LOW CONCENTRATIONS OF LITHIUM IONS INTO RAT CEREBRAL CORTEX SLICES AND ITS DEPENDENCE ON CATIONS , 1976, Journal of neurochemistry.

[18]  R. Roth,et al.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.

[19]  S. Iversen,et al.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.

[20]  W. D. Wise,et al.  Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. , 1974, Brain research.

[21]  S. Lorens,et al.  Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat. , 1974, Brain research.

[22]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[23]  K. Fuxe,et al.  Further mapping of central 5-hydroxytryptamine neurons: studies with the neurotoxic dihydroxytryptamines. , 1974, Advances in biochemical psychopharmacology.